SNDX Syndax Pharmaceuticals, Inc. - Common Stock
$20.34
价格 · 八月 20, 2026
截至...的财报数据 八月 4, 2026
52周区间
$13–$26
58% of range
分析师评级
BUY
19 analysts
目标价
$38
+86% upside
P/E (TTM)
-6.2
ROE
-257.1%
净利润率
-165.6%
SNDX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$20.34
市值
$1.78B
P/E (TTM)
-6.2
每股收益 (TTM)
$-3.29
营收 (TTM)
$172M
股息收益率
—
ROE
-257.1%
负债/权益
5.4
52周区间
$13 – $26
SNDX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$172M
2016-12-31
→
2025-12-31
EPS
$-3.29
2019-12-31
→
2025-12-31
自由现金流
$-323M
2016-12-31
→
2025-12-31
利润率
-165.6%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
SNDX
同行中位数
P/E (TTM)
-6.2
27.2
P/S (TTM) (市销率 (TTM))
10.3
25.4
P/B (市净率)
27.5
5.1
EV / EBITDA (企业价值 / EBITDA)
-6.3
—
Price / FCF (股价/自由现金流)
-5.5
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
SNDX
同行中位数
Operating Margin (营业利润率)
-158.4%
—
Net Profit Margin (净利润率)
-165.6%
-473.7%
ROA
-45.5%
-40.2%
ROE
-257.1%
-50.4%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
SNDX
同行中位数
Debt / Equity (负债/股东权益比率)
5.4
—
Current Ratio (流动比率)
4.4
9.0
Quick Ratio (速动比率)
3.6
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
SNDX
同行中位数
Revenue YoY (营收同比增长)
627.8%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-44.7%
—
Revenue CAGR 5Y (营收5年复合年增长率)
157.7%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
SNDX
同行中位数
SNDX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
19 位分析师
- 强烈买入 8 42.1%
- 买入 10 52.6%
- 持有 1 5.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
11 位分析师 · 2026-08-19
中位数
$37.00
← 低于所有目标
$20.34
最低
$26.00
最高
$57.00
中位数目标
$37.00
+81.9%
平均目标
$37.91
+86.4%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.07%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.55 | $-0.45 | -0.10% |
| 2026年3月31日 | $-0.48 | $-0.59 | 0.11% |
| 2025年12月31日 | $-0.78 | $-0.60 | -0.18% |
| 2025年9月30日 | $-0.70 | $-0.73 | 0.03% |
| 2025年6月30日 | $-0.83 | $-1.04 | 0.21% |
| 2025年3月31日 | $-0.98 | $-1.36 | 0.38% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| PURR | — | — | — | — | — | — |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | — |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | — |
| ANAB | — | -105.4 | 157.0% | — | — | — |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $172M | $24M | $0 | $0 | $140M | $2M | $2M | $2M | $2M | $1M | $627.0K | |
| R&D Expense | $259M | $242M | $163M | $118M | $88M | $50M | $43M | $60M | $48M | $32M | $10M | |
| SG&A Expense | $180M | $121M | $67M | $33M | $25M | $23M | $16M | $17M | $16M | $13M | $12M | |
| Operating Expenses | $445M | $363M | $230M | $152M | $113M | $73M | $59M | $77M | $64M | $45M | $21M | |
| Operating Income | $-273M | $-340M | $-230M | $-152M | $26M | $-71M | $-58M | $-76M | $-62M | $-44M | $-21M | |
| Interest Expense | · | · | $208.0K | $3M | $2M | $2M | · | · | · | · | · | |
| Interest Income | $23M | $26M | $21M | $6M | $403.0K | $841.0K | $2M | $2M | · | · | · | |
| Other Non-op | $-1M | $-247.0K | $-361.0K | $-316.0K | $202.0K | $-219.0K | $-79.0K | $-27.0K | $-269.0K | $41.0K | $-37.0K | |
| Income Tax | $433.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-285M | $-319M | $-209M | $-149M | $25M | $-73M | $-56M | $-74M | $-61M | $-44M | $-24M | |
| EPS (Basic) | $-3.29 | $-3.72 | $-2.98 | $-2.46 | $0.48 | $-1.87 | $-1.84 | · | · | · | · | |
| EPS (Diluted) | $-3.29 | $-3.72 | $-2.98 | $-2.46 | $0.46 | $-1.87 | $-1.84 | · | · | · | · | |
| Shares (Basic) | 86,625,610 | 85,622,065 | 70,370,519 | 60,760,906 | 52,064,809 | 41,308,242 | 30,490,783 | · | · | · | · | |
| Shares (Diluted) | 86,625,610 | 85,622,065 | 70,370,519 | 60,760,906 | 53,622,904 | 41,308,242 | 30,490,783 | · | · | · | · | |
| EBITDA | $-273M | $-340M | $-230M | $-152M | $26M | · | $-58M | · | $-62M | $-44M | · |
资产负债表 24
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $135M | $154M | $295M | $74M | $222M | $115M | $25M | $34M | $35M | $24M | $23M | |
| Short-term Investments | $259M | $419M | $275M | $401M | $218M | $178M | $35M | $47M | $95M | $81M | $63M | |
| Receivables | $38M | $8M | $0 | · | · | · | · | · | · | · | · | |
| Inventory | $33M | $366.0K | $0 | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $13M | $9M | $3M | $2M | $1M | $6M | $3M | $2M | $3M | $3M | $1M | |
| Other Current Assets | · | · | $0 | · | · | · | · | · | · | · | · | |
| Current Assets | $528M | $603M | $581M | $490M | $448M | $299M | $62M | $83M | $133M | $109M | $88M | |
| PP&E (Net) | $181.0K | $0 | $8.0K | $20.0K | $278.0K | $192.0K | $281.0K | $373.0K | $267.0K | $260.0K | $88.0K | |
| PP&E (Gross) | $606.0K | $419.0K | $419.0K | $419.0K | $721.0K | $591.0K | $591.0K | $608.0K | $466.0K | $540.0K | $280.0K | |
| Accum. Depreciation | $425.0K | $419.0K | $411.0K | $399.0K | $443.0K | $399.0K | $310.0K | $235.0K | $199.0K | $280.0K | $192.0K | |
| Other Non-current Assets | · | $0 | $463.0K | $807.0K | $0 | $1M | $197.0K | $219.0K | $231.0K | $243.0K | $2M | |
| Total Assets | $530M | $725M | $613M | $497M | $450M | $301M | $64M | $84M | $137M | $109M | $90M | |
| Accounts Payable | $17M | $12M | $10M | $4M | $6M | $4M | $6M | $1M | $2M | $2M | $1M | |
| Current Liabilities | $120M | $104M | $58M | $29M | $21M | $19M | $18M | $16M | $16M | $10M | $5M | |
| Capital Leases | · | $2M | $578.0K | $709.0K | $711.0K | $101.0K | $419.0K | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $1.0K | $5.0K | $136.0K | $310.0K | $288.0K | $70.0K | |
| Total Liabilities | $465M | $437M | $59M | $30M | $41M | $48M | $32M | $31M | $33M | $25M | $23M | |
| Total Debt | $350M | $338M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $9.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $471M | · | · | |
| Retained Earnings | $-1.51B | $-1.22B | $-902M | $-693M | $-544M | $-569M | $-495M | $-439M | $-366M | $-305M | $-260M | |
| Stockholders' Equity | $65M | $288M | $554M | $467M | $408M | $252M | $32M | $53M | $104M | $84M | $-252M | |
| Liabilities + Equity | $530M | $725M | $613M | $497M | $450M | $301M | $64M | $84M | $137M | $109M | $90M | |
| Shares Outstanding | 87,405,979 | 85,694,443 | 84,826,632 | 68,111,385 | 54,983,105 | 47,881,223 | 27,140,484 | 24,835,951 | 24,390,033 | 18,215,181 | 85,440 |
现金流 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $48M | $43M | $31M | $16M | $13M | $9M | $6M | $6M | $5M | $5M | $4M | |
| Operating Cash Flow | $-323M | $-275M | $-161M | $-134M | $29M | $-71M | $-51M | $-69M | $-47M | $-35M | $-2M | |
| CapEx | $187.0K | $0 | $0 | $0 | $129.0K | $0 | · | $187.0K | $84.0K | $261.0K | $49.0K | |
| Investing Cash Flow | $290M | $-220M | $118M | $-186M | $-41M | $-143M | $13M | $51M | $-17M | $-18M | · | |
| Financing Cash Flow | $14M | $353M | $264M | $172M | $118M | $304M | $29M | $16M | $76M | $54M | · | |
| Net Change in Cash | $-19M | $-141M | $221M | $-148M | $107M | $91M | $-9M | $-1M | $11M | $762.0K | $13M | |
| Taxes Paid | $150 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-323M | · | $-161M | $-134M | $29M | · | · | · | $-47M | $-35M | · |
盈利能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -158.4% | -1434.4% | · | · | 18.8% | · | -3792.9% | · | -2939.0% | -3587.4% | · | |
| Net Margin | -165.6% | -1346.1% | · | · | 17.8% | · | -3694.6% | · | -2884.3% | -3645.2% | · | |
| EBITDA Margin | -158.4% | -1434.4% | · | · | 18.8% | · | -3792.9% | · | -2939.0% | -3587.4% | · | |
| ROA | -45.5% | -47.7% | -37.7% | -31.5% | 6.6% | · | -76.0% | · | -49.4% | -44.7% | · | |
| ROE | -257.1% | -97.4% | -45.8% | -37.1% | 8.2% | · | -148.2% | · | -64.5% | 52.9% | · |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.4 | 5.8 | 10.0 | 16.9 | 21.7 | · | 3.4 | · | 8.4 | 10.5 | · | |
| Quick Ratio | 3.6 | 5.6 | 9.8 | 16.4 | 21.3 | · | 3.3 | · | 8.2 | 10.2 | · | |
| Debt / Equity | 5.4 | 1.2 | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | -1105.5 | -48.4 | 13.8 | · | · | · | · | · | · |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.0 | 0.0 | · | 0.4 | · | 0.0 | · | 0.0 | 0.0 | · | |
| Receivables Turnover | 7.6 | 6.2 | · | · | · | · | · | · | · | · | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 627.8% | · | · | · | 9109.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -44.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 157.7% | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $172M | $24M | $0 | $0 | $140M | $2M | $2M | $2M | $2M | $1M | · | |
| Net Income TTM | $-285M | $-319M | $-209M | $-149M | $25M | $-73M | $-56M | $-74M | $-61M | $-44M | · | |
| Market Cap | $1.84B | $1.13B | $1.83B | $1.73B | $1.20B | · | $238M | · | $214M | $131M | · | |
| Enterprise Value | $1.79B | $898M | · | · | · | · | · | · | · | · | · | |
| P/E | -6.4 | -3.6 | -7.3 | -10.3 | 47.6 | -11.9 | -4.8 | · | · | · | · | |
| P/S | 10.7 | 47.8 | · | · | 8.6 | · | 157.1 | · | 101.4 | 107.1 | · | |
| P/B | 28.4 | 3.9 | 3.3 | 3.7 | 2.9 | · | 7.5 | · | 2.0 | 1.6 | · | |
| P / Tangible Book | 28.4 | 3.9 | 3.3 | 3.7 | 2.9 | 4.2 | · | · | · | · | · | |
| P / Cash Flow | -5.7 | -4.1 | -11.4 | -13.0 | 41.3 | · | -4.7 | · | -4.5 | -3.7 | · | |
| P / FCF | -5.7 | · | -11.4 | -13.0 | 41.5 | · | · | · | -4.5 | -3.7 | · | |
| EV / EBITDA | -6.6 | -2.6 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -5.5 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 10.4 | 37.9 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -15.7% | -28.1% | -13.8% | -9.7% | 2.1% | -8.4% | -21.0% | · | · | · | · |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $73M | $65M | $68M | $46M | $38M | $20M | $8M | $12M | $4M | $0 | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $68M | $59M | $79M | $56M | $62M | $62M | $66M | $71M | $49M | $56M | $55M | $39M | $35M | $34M | $32M | $27M | |
| SG&A Expense | $42M | $38M | $50M | $45M | $44M | $41M | $38M | $31M | $29M | $23M | $23M | $17M | $15M | $12M | $10M | $8M | |
| Operating Expenses | $113M | $99M | $131M | $103M | $107M | $104M | $104M | $102M | $78M | $80M | $78M | $56M | $50M | $46M | $42M | $35M | |
| Operating Income | $-40M | $-34M | $-63M | $-57M | $-69M | $-84M | $-96M | $-90M | $-74M | $-80M | $-78M | $-56M | $-50M | $-46M | $-42M | $-35M | |
| Interest Expense | · | · | · | · | · | · | · | · | $45.0K | $55.0K | · | $70.0K | $35.0K | $40.0K | · | $2M | |
| Interest Income | $4M | $4M | $4M | $5M | $6M | $7M | $7M | $5M | $6M | $7M | $6M | $5M | $5M | $5M | $3M | $2M | |
| Other Non-op | $-438.0K | $-186.0K | $3M | $-275.0K | $-586.0K | $-221.0K | $-14M | $32.0K | $6M | $7M | $-55.0K | $-66.0K | $-93.0K | $-147.0K | $-106.0K | $-295.0K | |
| Income Tax | $0 | $0 | $433.0K | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-49M | $-43M | $-68M | $-61M | $-72M | $-85M | $-94M | $-84M | $-68M | $-72M | $-72M | $-51M | $-45M | $-41M | $-39M | $-35M | |
| EPS (Basic) | $-0.55 | $-0.48 | $-0.78 | $-0.70 | $-0.83 | $-0.98 | $-1.09 | $-0.98 | $-0.80 | $-0.85 | $-1.02 | $-0.73 | $-0.64 | $-0.59 | $-0.63 | $-0.58 | |
| EPS (Diluted) | $-0.55 | $-0.48 | $-0.78 | $-0.70 | $-0.83 | $-0.98 | $-1.09 | $-0.98 | $-0.80 | $-0.85 | $-1.02 | $-0.73 | $-0.64 | $-0.59 | $-0.63 | $-0.58 | |
| Shares (Basic) | 88,991,317 | 88,255,636 | -172,504,508 | 86,620,992 | 86,337,237 | 86,171,889 | -170,299,533 | 85,433,569 | 85,274,829 | 85,213,200 | -138,562,564 | 69,855,766 | 69,638,427 | 69,438,890 | -119,044,656 | 60,670,294 | |
| Shares (Diluted) | 88,991,317 | 88,255,636 | -172,504,508 | 86,620,992 | 86,337,237 | 86,171,889 | -170,299,533 | 85,433,569 | 85,274,829 | 85,213,200 | -138,562,564 | 69,855,766 | 69,638,427 | 69,438,890 | -119,044,656 | 60,670,294 | |
| EBITDA | $-40M | $-34M | · | $-57M | $-69M | $-84M | · | $-90M | $-74M | $-80M | · | $-56M | $-50M | $-46M | · | $-35M |
资产负债表 22
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $336M | $131M | $135M | $117M | $109M | $154M | $154M | $133M | $105M | $115M | $295M | $95M | $97M | $58M | $74M | $71M | |
| Short-term Investments | $211M | $221M | $259M | $319M | $347M | $358M | $419M | $257M | $320M | $320M | · | $269M | $302M | $375M | · | $266M | |
| Receivables | · | · | $38M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Inventory | $33M | $35M | $33M | $25M | $18M | $5M | $366.0K | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $17M | $16M | $13M | $10M | $10M | $8M | $9M | $5M | $4M | $5M | · | $4M | $3M | $2M | · | $2M | |
| Other Current Assets | · | · | · | · | · | · | · | $4M | $10M | $6M | · | · | · | · | · | · | |
| Current Assets | $675M | $471M | $528M | $530M | $532M | $549M | $603M | $415M | $446M | $454M | · | $381M | $409M | $442M | · | $358M | |
| PP&E (Net) | $212.0K | $177.0K | $181.0K | $128.0K | $0 | $0 | $0 | $0 | $2.0K | $5.0K | · | $10.0K | $13.0K | $17.0K | · | $23.0K | |
| PP&E (Gross) | $646.0K | $606.0K | $606.0K | · | · | · | $419.0K | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $434.0K | $429.0K | $425.0K | · | · | · | $419.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | $0 | $156.0K | $248.0K | · | $587.0K | $579.0K | $693.0K | · | $881.0K | |
| Total Assets | $704M | $473M | $530M | $552M | $596M | $641M | $725M | $426M | $477M | $543M | · | $399M | $431M | $460M | · | $360M | |
| Accounts Payable | $5M | $11M | $17M | $14M | $17M | $10M | $12M | $5M | $12M | $9M | · | $6M | $11M | $8M | · | $7M | |
| Current Liabilities | $100M | $86M | $120M | $114M | $113M | $95M | $104M | $59M | $42M | $51M | · | $39M | $30M | $24M | · | $21M | |
| Capital Leases | · | · | · | · | · | · | · | $0 | $133.0K | $327.0K | · | $851.0K | $1M | $588.0K | · | $768.0K | |
| Total Liabilities | $689M | $431M | $465M | $436M | $439M | $426M | $437M | $59M | $43M | $51M | · | $40M | $31M | $24M | · | $22M | |
| Total Debt | $350M | $350M | · | $327M | $331M | $336M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | · | $7.0K | $7.0K | $7.0K | · | $6.0K | |
| Retained Earnings | $-1.60B | $-1.55B | $-1.51B | $-1.44B | $-1.38B | $-1.31B | $-1.22B | $-1.13B | $-1.04B | $-975M | · | $-830M | $-779M | $-734M | · | $-654M | |
| Stockholders' Equity | $15M | $42M | $65M | $115M | $157M | $215M | $288M | $366M | $434M | $492M | $554M | $359M | $400M | $436M | $467M | $338M | |
| Liabilities + Equity | $704M | $473M | $530M | $552M | $596M | $641M | $725M | $426M | $477M | $543M | · | $399M | $431M | $460M | · | $360M | |
| Shares Outstanding | 89,150,619 | 88,543,881 | 87,405,979 | 86,905,343 | 86,059,077 | 86,047,032 | 85,694,443 | 85,571,205 | 85,028,629 | 84,979,686 | · | 69,638,168 | 69,431,198 | 68,495,426 | · | 60,122,661 |
现金流 6
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $12M | $11M | $12M | $14M | $10M | $12M | $12M | $10M | $9M | $8M | $8M | $8M | $6M | $4M | $4M | |
| Operating Cash Flow | $-30M | $-50M | $-69M | $-71M | $-88M | $-95M | $-57M | $-62M | $-72M | $-84M | $-41M | $-45M | $-35M | $-39M | $-23M | $-29M | |
| Investing Cash Flow | $-17M | $38M | $82M | $72M | $42M | $94M | $-269M | $87M | $62M | $-99M | $-16M | $40M | $74M | $20M | $-138M | $-7M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | |
| Financing Cash Flow | $253M | $8M | $6M | $6M | $551.0K | $930.0K | $347M | $3M | $676.0K | $2M | $258M | $2M | $1M | $2M | $164M | $-14M | |
| Net Change in Cash | $206M | $-4M | $18M | $8M | $-45M | $-90.0K | $21M | $28M | $-9M | $-181M | $201M | $-3M | $40M | $-17M | $3M | $-49M |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -54.9% | -52.7% | · | -125.2% | -182.7% | -417.9% | · | -716.6% | -2120.5% | · | · | · | · | · | · | · | |
| Net Margin | -67.8% | -65.8% | · | -132.4% | -189.3% | -423.3% | · | -673.0% | -1944.7% | · | · | · | · | · | · | · | |
| EBITDA Margin | -54.9% | -52.7% | · | -125.2% | -182.7% | -417.9% | · | -716.6% | -2120.5% | · | · | · | · | · | · | · | |
| ROA | -7.6% | -7.7% | · | -12.4% | -13.4% | -14.3% | · | -20.4% | -15.0% | -14.4% | · | -13.5% | -10.7% | -9.3% | · | -11.8% | |
| ROE | -57.2% | -33.2% | · | -25.2% | -24.3% | -24.0% | · | -23.2% | -16.3% | -15.6% | · | -14.7% | -11.7% | -10.2% | · | -13.2% |
流动性与偿付能力 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.8 | 5.5 | · | 4.6 | 4.7 | 5.8 | · | 7.0 | 10.5 | 8.9 | · | 9.7 | 13.6 | 18.6 | · | 17.2 | |
| Quick Ratio | 5.5 | 4.1 | · | 3.8 | 4.0 | 5.4 | · | 6.6 | 10.0 | 8.6 | · | 9.3 | 13.2 | 18.2 | · | 16.2 | |
| Debt / Equity | 23.2 | 8.4 | · | 2.8 | 2.1 | 1.6 | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -1649.2 | -1445.7 | · | -805.1 | -1419.4 | -1150.4 | · | -20.1 |
效率 1
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · |
估值 (TTM) 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $221M | $169M | · | $116M | $74M | $36M | · | $16M | $4M | · | · | · | · | $14M | · | $14M | |
| Net Income TTM | $-225M | $-260M | · | $-302M | $-309M | $-309M | · | $-276M | $-236M | $-209M | · | $-172M | $-159M | $-151M | · | $-131M | |
| Market Cap | $1.95B | $2.07B | · | $1.34B | $806M | $1.06B | · | $1.65B | $1.75B | $2.02B | · | $1.01B | $1.45B | $1.45B | · | $1.44B | |
| Enterprise Value | $1.75B | $2.07B | · | $1.23B | $681M | $881M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -8.5 | -7.8 | · | -4.4 | -2.6 | -3.4 | · | -5.7 | -6.8 | -8.5 | · | -5.7 | -8.6 | -8.7 | · | -10.8 | |
| P/S | 8.8 | 12.3 | · | 11.5 | 10.9 | 29.3 | · | 103.0 | 498.8 | · | · | · | · | 107.1 | · | 106.9 | |
| P/B | 129.1 | 49.7 | · | 11.6 | 5.1 | 4.9 | · | 4.5 | 4.0 | 4.1 | · | 2.8 | 3.6 | 3.3 | · | 4.3 | |
| P / Tangible Book | 129.1 | 49.7 | · | 11.6 | 5.1 | 4.9 | · | 4.5 | 4.0 | 4.1 | · | 2.8 | 3.6 | 3.3 | · | 4.3 | |
| P / Cash Flow | · | -41.1 | · | · | · | -11.1 | · | · | · | -24.2 | · | · | · | -36.9 | · | · | |
| EV / EBITDA | -43.8 | -60.4 | · | -21.4 | -9.8 | -10.5 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 7.9 | 12.2 | · | 10.6 | 9.2 | 24.4 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -11.7% | -12.8% | · | -22.7% | -38.3% | -29.4% | · | -17.4% | -14.7% | -11.8% | · | -17.5% | -11.6% | -11.5% | · | -9.3% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $172M | $24M | $0 | $0 | $140M |
| 营业利润率 % | -158.4% | -1434.4% | — | — | 18.8% |
| 净收入 | $-285M | $-319M | $-209M | $-149M | $25M |
| 稀释后每股收益 (EPS) | $-3.29 | $-3.72 | $-2.98 | $-2.46 | $0.46 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 5.4 | 1.2 | — | — | — |
| 流动比率 | 4.4 | 5.8 | 10.0 | 16.9 | 21.7 |
| 速动比率 | 3.6 | 5.6 | 9.8 | 16.4 | 21.3 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-323M | — | $-161M | $-134M | $29M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 264 家申报者 · $1.8B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 42 (-4 与上一季度对比) | 36 (+11 与上一季度对比) | 84 (-10 与上一季度对比) | 81 (+5 与上一季度对比) | +9.2M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Kynam Capital Management, LP | $175993964 | 8050959 | 9.56% | 股份 |
| STATE STREET CORP | $123693149 | 5658424 | 6.72% | 股份 |
| GOLDMAN SACHS GROUP INC | $118916323 | 5439905 | 6.46% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $85863719 | 3927892 | 4.66% | 股份 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $82628614 | 3779900 | 4.49% | 股份 |
| Eversept Partners, LP | $61168871 | 2798210 | 3.32% | 股份 |
| Hood River Capital Management LLC | $56055139 | 2564279 | 3.05% | 股份 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $54650000 | 2500000 | 2.97% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $49304935 | 2255013 | 2.68% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $44899566 | 2053960 | 2.44% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $42010461 | 1921796 | 2.28% | 股份 |
| Elmind Capital, LP | $40550300 | 1855000 | 2.20% | 股份 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $39106294 | 1788943 | 2.12% | 股份 |
| Candriam S.C.A. | $37039763 | 1696040 | 2.01% | 股份 |
| Soleus Capital Management, L.P. | $35588933 | 1628039 | 1.93% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $34497812 | 1578125 | 1.87% | 股份 |
| ORBIMED ADVISORS LLC | $33708120 | 1542000 | 1.83% | 股份 |
| MPM BIOIMPACT LLC | $29150813 | 1333523 | 1.58% | 股份 |
| Aisling Capital Management LP | $28785379 | 1316806 | 1.56% | 股份 |
| Woodline Partners LP | $27341614 | 1250760 | 1.49% | 股份 |
| Catalio Capital Management, LP | $26575158 | 1215698 | 1.44% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $26546565 | 1214390 | 1.44% | 股份 |
| Prosight Management, LP | $26232000 | 1200000 | 1.43% | 股份 |
| Trails Edge Capital Partners, LP | $24264600 | 1110000 | 1.32% | 股份 |
| ALGERT GLOBAL LLC | $22985025 | 1051465 | 1.25% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $22179287 | 1014606 | 1.20% | 股份 |
| Parkman Healthcare Partners LLC | $19176816 | 877256 | 1.04% | 股份 |
| Ensign Peak Advisors, Inc | $18970786 | 867831 | 1.03% | 股份 |
| Palo Alto Investors LP | $18908594 | 864986 | 1.03% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17800664 | 814303 | 0.97% | 股份 |
| LOOMIS SAYLES & CO L P | $16788611 | 768006 | 0.91% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $13848507 | 633509 | 0.75% | 股份 |
| TWO SIGMA ADVISERS, LP | $13294120 | 632752 | 0.72% | 股份 |
| Rhenman & Partners Asset Management AB | $12247065 | 560250 | 0.67% | 股份 |
| Apis Capital Advisors, LLC | $12154160 | 556000 | 0.66% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $11946862 | 546517 | 0.65% | 股份 |
| BANK OF AMERICA CORP /DE/ | $10822930 | 495102 | 0.59% | 股份 |
| Qube Research & Technologies Ltd | $10431199 | 477182 | 0.57% | 股份 |
| Bank of New York Mellon Corp | $9995135 | 457234 | 0.54% | 股份 |
| FIRST TRUST ADVISORS LP | $9983462 | 456700 | 0.54% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9926648 | 454101 | 0.54% | 股份 |
| Granahan Investment Management, LLC | $9771158 | 446988 | 0.53% | 股份 |
| Knott David M Jr | $9558176 | 437245 | 0.52% | 股份 |
| Aberdeen Group plc | $8148665 | 372766 | 0.44% | 股份 |
| Squarepoint Ops LLC | $8095130 | 370317 | 0.44% | 股份 |
| JUPITER ASSET MANAGEMENT LTD | $8013176 | 366568 | 0.44% | 股份 |
| AMERIPRISE FINANCIAL INC | $7526717 | 344354 | 0.41% | 股份 |
| Jones Hill Capital LP | $7432400 | 340000 | 0.40% | 股份 |
| DAFNA Capital Management LLC | $7328674 | 335255 | 0.40% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $7161708 | 327617 | 0.39% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $7030176 | 321600 | 0.38% | 股份 |
| Brevan Howard Capital Management LP | $6756161 | 309065 | 0.37% | 股份 |
| Alyeska Investment Group, L.P. | $6743963 | 308507 | 0.37% | 股份 |
| Verition Fund Management LLC | $6665967 | 304939 | 0.36% | 股份 |
| D. E. Shaw & Co., Inc. | $6325060 | 289344 | 0.34% | 股份 |
| BlackRock, Inc. | $6274957 | 287052 | 0.34% | 股份 |
| MACKENZIE FINANCIAL CORP | $6122527 | 280079 | 0.33% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5670484 | 259400 | 0.31% | 买入期权 |
| CITADEL ADVISORS LLC | $5645957 | 258278 | 0.31% | 股份 |
| Trexquant Investment LP | $5595045 | 255949 | 0.30% | 股份 |
| SECTOR GAMMA AS | $5284415 | 241739 | 0.29% | 股份 |
| Schonfeld Strategic Advisors LLC | $5174631 | 236717 | 0.28% | 股份 |
| Pinnacle Financial Partners, Inc. | $4747402 | 217173 | 0.26% | 股份 |
| Man Group plc | $4671548 | 213703 | 0.25% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $4649906 | 212713 | 0.25% | 股份 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $4530485 | 207250 | 0.25% | 股份 |
| Pictet Asset Management Holding SA | $4529835 | 207936 | 0.25% | 股份 |
| Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group | $4372000 | 200000 | 0.24% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $3935000 | 180000 | 0.21% | 股份 |
| Cubist Systematic Strategies, LLC | $3796689 | 246779 | 0.21% | 股份 |
| Swiss National Bank | $3674666 | 168100 | 0.20% | 股份 |
| Atom Investors LP | $3552775 | 162524 | 0.19% | 股份 |
| SummitTX Capital, L.P. | $3077822 | 140797 | 0.17% | 股份 |
| Torray Investment Partners LLC | $2925633 | 133835 | 0.16% | 股份 |
| RHUMBLINE ADVISERS | $2893331 | 132358 | 0.16% | 股份 |
| Pale Fire Capital SE | $2744523 | 125550 | 0.15% | 股份 |
| CAPITAL FUND MANAGEMENT S.A. | $2734489 | 125091 | 0.15% | 股份 |
| PFM Health Sciences, LP | $2588705 | 118422 | 0.14% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2482201 | 113967 | 0.13% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $2477094 | 106040 | 0.13% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2406290 | 103009 | 0.13% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $2366214 | 108244 | 0.13% | 股份 |
| Rafferty Asset Management, LLC | $2137624 | 97787 | 0.12% | 股份 |
| TEMA ETFS LLC | $2102114 | 100053 | 0.11% | 股份 |
| HUSSMAN STRATEGIC ADVISORS, INC. | $1836240 | 84000 | 0.10% | 股份 |
| Aquatic Capital Management LLC | $1725235 | 78922 | 0.09% | 股份 |
| WINTON GROUP Ltd | $1672290 | 76500 | 0.09% | 股份 |
| Seven Fleet Capital Management LP | $1645046 | 77930 | 0.09% | 股份 |
| CITADEL ADVISORS LLC | $1538944 | 70400 | 0.08% | 买入期权 |
| 1492 Capital Management LLC | $1464554 | 66997 | 0.08% | 股份 |
| Virtus Investment Advisers, LLC | $1392919 | 63720 | 0.08% | 股份 |
| CITIGROUP INC | $1311600 | 60000 | 0.07% | 买入期权 |
| CITIGROUP INC | $1311600 | 60000 | 0.07% | 卖出期权 |
| XTX Topco Ltd | $1293325 | 59164 | 0.07% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1276755 | 58406 | 0.07% | 股份 |
| Headlands Technologies LLC | $1229122 | 56227 | 0.07% | 股份 |
| IEQ CAPITAL, LLC | $1198693 | 54835 | 0.07% | 股份 |
| MetLife Investment Management, LLC | $1135190 | 51930 | 0.06% | 股份 |
| BARCLAYS PLC | $1084256 | 49600 | 0.06% | 买入期权 |
| PROFUND ADVISORS LLC | $1080146 | 49412 | 0.06% | 股份 |
公司内部人士 14 位内幕人士 · 4 位高管 · 11 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Michael A Metzger | Chief Executive Officer | 2026年7月8日 M | 484843 | 0 | 5 | $-4009892 |
| Keith A. Goldan | Chief Financial Officer | 2026年6月1日 S | 139252 | 0 | 3 | $-136994 |
| Neil Gallagher | President, Head of R&D | 2025年2月10日 S | 85095 | 0 | 0 | $0 |
| Nicholas A.J. Botwood | Head of R&D, CMO | 2026年6月12日 M | 60885 | 0 | 2 | $-1183643 |
| Aleksandra Rizo | 董事 | 2026年2月4日 A | 49000 | 0 | 0 | $0 |
| Jennifer Jarrett | 董事 | 2026年2月4日 A | 114000 | 0 | 0 | $0 |
| Martin H. Huber Jr. | 董事 | 2026年2月4日 A | 103000 | 0 | 0 | $0 |
| Pierre Legault | 董事 | 2026年2月4日 A | 114000 | 0 | 0 | $0 |
| Keith Katkin | 董事 | 2026年2月4日 A | 124000 | 0 | 0 | $0 |
| Dennis Podlesak | 董事 | 2026年2月4日 A | 239763 | 0 | 0 | $0 |
| William Meury | 董事 | 2025年2月5日 A | 90000 | 0 | 0 | $0 |
| Kim P. Kamdar | 董事 | 2016年10月31日 A | — | 0 | 0 | $0 |
| Luke Evnin | 董事 | 2016年3月8日 C | 2168691 | 0 | 0 | $0 |
| Ivor Royston | 董事 | 2016年3月8日 C | 750545 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Access Industries Holdings LLC, AI Life Sciences Investments LLC, AI LSI-SPV LLC, Access Industries Holdings (BVI) L.P., Access Industries, LLC, Access Industries Management, LLC, Len Blavatnik ×2 申报 | 2022年3月4日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 39 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.68% | 46457 NS | 2026年4月30日 | N-PORT |
| CANC · Tema ETF Trust | 0.80% | 72212 NS | 2026年5月31日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.55% | 134242 NS | 2026年4月30日 | N-PORT |
| FYC · First Trust Exchange-Traded Alpha... | 0.51% | 249549 NS | 2026年4月30日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.26% | 148598 NS | 2026年4月30日 | N-PORT |
| ESSC · Strategy Shares | 0.13% | 1602 NS | 2026年4月30日 | N-PORT |
| FAD · First Trust Exchange-Traded Alpha... | 0.10% | 23307 NS | 2026年4月30日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.09% | 30651 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 0.09% | 3261 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.06% | 37359 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.04% | 4050 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.04% | 416170 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 37483 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.02% | 3168 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.02% | 3204 NS | 2026年5月31日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.02% | 8464 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 3522 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 80 NS | 2026年5月31日 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 6314 NS | 2026年4月30日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 28259 NS | 2026年5月31日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 52906 NS | 2026年5月31日 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.00% | 204 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 2026年7月30日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWO · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBB · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026年7月23日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| ISCB · iShares Trust | — | — | 2026年8月5日 | 每日 |
| ISCG · iShares Trust | — | — | 2026年8月5日 | 每日 |
| WSML · iShares Trust | — | — | 2026年8月5日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |